![Oded S. Lieberman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Oded S.
Lieberman served as Chairman & CEO of NeuroDerm Ltd.
and President & CEO of Geffen Residence & Renewal Ltd.
He was also President & CEO of Proteologics, Inc. and Vice President-Surgical Products at OMRIX Biopharmaceuticals, Inc. Additionally, he served as General Manager-Surgical Products at Octapharma AG and as a Principal at Roche Diagnostics GmbH.
Lieberman holds an undergraduate degree and a doctorate from The Hebrew University of Jerusalem, as well as an MBA from INSEAD.
Former positions of Oded S. Lieberman
Companies | Position | End |
---|---|---|
Proteologics, Inc. | Chief Executive Officer | 2003-12-31 |
OMRIX Biopharmaceuticals, Inc.
![]() OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Corporate Officer/Principal | 1998-12-31 |
GEFFEN RESIDENCE & RENEWAL LTD | Chief Executive Officer | - |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Corporate Officer/Principal | - |
Octapharma AG
![]() Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Corporate Officer/Principal | - |
Training of Oded S. Lieberman
INSEAD | Masters Business Admin |
The Hebrew University of Jerusalem | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GEFFEN RESIDENCE & RENEWAL LTD | Process Industries |
Private companies | 5 |
---|---|
OMRIX Biopharmaceuticals, Inc.
![]() OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
Octapharma AG
![]() Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Health Technology |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
NeuroDerm Ltd.
![]() NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Proteologics, Inc. |
- Stock Market
- Insiders
- Oded S. Lieberman